Legend Biotech · 1 day ago
CQV Intern
Raritan, NJ
Internship
Onsite
InternLegend Biotech is a global biotechnology company dedicated to treating life-threatening diseases. They are seeking a CQV Intern to learn about Commissioning and Qualification (C&Q) SOPs, update databases, and shadow C&Q activities, providing exposure to GMP requirements for equipment and facilities.
BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Responsibilities
Learn about C&Q SOPs and approaches
Update databases and scan binders
Shadow C&Q activities
Gain understanding of GMP requirements for equipment and facilities
Qualification
Required
Education: Senior-level student
Experience & Skills: Not specified; interest in C&Q and GMP environments
Desired Academic Grade Level: Senior
Benefits
Medical, dental, and vision insurance
401(k)-retirement plan with company match that vest fully on day one
Equity and stock options are available to employees in eligible roles
Eight weeks of paid parental leave after just three months of employment
Paid time off policy that includes vacation days, personal days, sick time, 11 company holidays, and 3 floating holidays
Flexible spending and health savings accounts
Life and AD&D insurance
Short- and long-term disability coverage
Legal assistance
Supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance
Commuter benefits
Family planning and care resources
Well-being initiatives
Peer-to-peer recognition programs
Company
Legend Biotech
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Founded in 2014
1001-5000 employees
H1B Sponsorship
Legend Biotech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (30)
2024 (11)
2023 (14)
2022 (7)
2021 (6)
2020 (13)
Funding
Current Stage
Public CompanyTotal Funding
$750.45M2023-05-05Post Ipo Equity· $350M
2022-07-25Post Ipo Equity· $250M
2020-06-05IPO
Leadership Team
Carlos Santos
Chief Financial Officer
Alan Bash
President, CARVYKTI
Recent News
2025-12-18
Company data provided by crunchbase